NF-kappa B and TNF-alpha: a positive autocrine loop in human lung mast cells?
The generation of cytokines, particularly TNF-alpha, by mast cells is crucial for the initiation of the allergic response. A key transcription factor involved in the synthesis of TNF-alpha is NF-kappaB. Using a mAb specific for the activated form of NF-kappaB, immunocytochemistry, confocal microscopy, and gel shift assays have been used in conjunction to localize this transcription factor to human lung mast cells and to study its activation. Activation of mast cells with stem cell factor (10 ng/ml) and anti-IgE (1 micro g/ml) induced maximal activation of NF-kappaB at 4 and 2 h, respectively. In contrast, with TNF-alpha (5 ng/ml) maximal activation occurred within 15 min. Parallel falls in IkappaB were demonstrated. Confocal microscopy demonstrated the localization of the activated form of NF-kappaB to the nuclei of activated mast cells. NF-kappaB activation was verified using a gel shift assay. A supershift assay showed mast cell NF-kappaB to be composed primarily of p50 with smaller amounts of p65. No interaction with Abs for Rel-A, c-Rel, Rel-B, and p52 was seen. Immunocytochemistry and ELISAs showed TNF-alpha to be stored within mast cells and released into the extracellular environment following activation. The possible participation of TNF-alpha generated by mast cells in NF-kappaB activation by anti-IgE was investigated using a blocking Ab for TNF-alpha. The blocking Ab reduced NF-kappaB activation by anti-IgE by >50%, suggesting that the release of preformed mast cell-associated TNF-alpha acts as a positive autocrine feedback signal to augment NF-kappaB activation and production of further cytokine, including GM-CSF and IL-8.
Coward
William R
WR
Division of Infection, Inflammation and Repair, School of Medicine, Southampton General Hospital, United Kingdom.
Okayama
Yoshimichi
Y
Sagara
Hironori
H
Wilson
Susan J
SJ
Holgate
Stephen T
ST
Church
Martin K
MK
D021581:Active Transport, Cell Nucleus / Q000502:physiology; D000888:Antibodies, Anti-Idiotypic / Q000494:pharmacology; D019898:Autocrine Communication / Q000502:physiology*; D002467:Cell Nucleus / Q000378:metabolism; D002478:Cells, Cultured; D016207:Cytokines / Q000096:biosynthesis; D004591:Electrophoresis, Polyacrylamide Gel; D006801:Humans; D020672:I-kappa B Proteins / Q000037:antagonists & inhibitors / Q000276:immunology / Q000378:metabolism; D007073:Immunoglobulin E / Q000276:immunology; D007150:Immunohistochemistry; D007700:Kinetics; D008168:Lung / Q000166:cytology* / Q000378:metabolism / Q000502:physiology*; D008407:Mast Cells / Q000378:metabolism / Q000502:physiology*; D018613:Microscopy, Confocal; D016328:NF-kappa B / Q000037:antagonists & inhibitors / Q000378:metabolism / Q000502:physiology*; D019089:Stem Cell Factor / Q000494:pharmacology; D014409:Tumor Necrosis Factor-alpha / Q000096:biosynthesis / Q000494:pharmacology / Q000502:physiology*
D000888:Antibodies, Anti-Idiotypic; D016207:Cytokines; D020672:I-kappa B Proteins; D016328:NF-kappa B; D019089:Stem Cell Factor; D014409:Tumor Necrosis Factor-alpha; C026408:anti-IgE antibodies; D007073:Immunoglobulin E